Horizon Technology Finance Provides Fourth Quarter 2022 Portfolio Update
– Horizon Platform Originates $114 Million of New Loans in Q4, Including $104 Million of New Loans for HRZN –
– HRZN Grows Loan Portfolio by $262 Million in 2022 –
– Horizon Platform Ends 2022 with Committed Backlog of $255 Million, Including $220 Million in HRZN Commitments –
Related news for (EVLO)
- Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis
- Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis
- Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights
- Evelo Biosciences Closes $25.5 Million Private Placement
- Evelo Biosciences Announces $25.5 Million Private Placement
